drugset
drugset / Trial / NCT03317730

Pilot Trial of Microsphere Oxycodone (Xtampza ER) for Pain Management in Patients Receiving Radiotherapy for Locally Advanced Head and Neck Cancer

NCT03317730 ↗

Phase 0 Completed 28 enrolled University of Alabama at Birmingham
NaSingle-groupOpen-labelTreatment

Summary

To confirm the feasibility of studying Xtampza ER during radiotherapy (RT) for LAHNC as part of a prospective clinical trial.

Timeline

Start
2018-05-01
Primary completion
2019-12-04
Completion
2020-11-17

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxycodone Other / unclassified — Oral

Indications

head and neck cancer